» Articles » PMID: 38238005

Phenotypic and Genetically Predicted Leucocyte Telomere Length and Lung Cancer Risk in the Prospective UK Biobank

Overview
Journal Thorax
Date 2024 Jan 18
PMID 38238005
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated phenotypic leucocyte telomere length (LTL), genetically predicted LTL (gTL), and lung cancer risk among 371 890 participants, including 2829 incident cases, from the UK Biobank. Using multivariable Cox regression, we found dose-response relationships between longer phenotypic LTL (p-trend=2.6×10), longer gTL predicted using a polygenic score with 130 genetic instruments (p-trend=4.2×10), and overall lung cancer risk, particularly for adenocarcinoma. The associations were prominent among never smokers. Mendelian Randomization analyses supported causal associations between longer telomere length and lung cancer (HR=1.87, 95% CI: 1.49 to 2.36, p=4.0×10), particularly adenocarcinoma (HR=2.45, 95%CI: 1.69 to 3.57, p=6.5×10).

Citing Articles

Exploration of telomere-related biomarkers for lung adenocarcinoma and targeted drug prediction.

Zhao J, Ye L, Yan W, Huang W, Wang G Discov Oncol. 2025; 16(1):148.

PMID: 39928198 PMC: 11811357. DOI: 10.1007/s12672-025-01847-2.


Leukocytes telomere length as a biomarker of adverse drug reactions induced by Osimertinib in advanced non-small cell lung cancer.

Trachu N, Reungwetwattana T, Meanwatthana J, Sukasem C, Majam T, Saengsiwaritt W Sci Rep. 2024; 14(1):26543.

PMID: 39489788 PMC: 11532503. DOI: 10.1038/s41598-024-77935-0.


Leucocyte Telomere Length and Lung Cancer Risk: A Systematic Review and Meta-Analysis of Prospective Studies.

Fabiani R, Chiavarini M, Rosignoli P, Giacchetta I Cancers (Basel). 2024; 16(18).

PMID: 39335189 PMC: 11430440. DOI: 10.3390/cancers16183218.


Genetic susceptibility to chronic diseases leads to heart failure among Europeans: the influence of leukocyte telomere length.

Wong J, Blechter B, Liu Z, Shi J, Roger V Hum Mol Genet. 2024; 33(14):1262-1272.

PMID: 38676403 PMC: 11227624. DOI: 10.1093/hmg/ddae063.

References
1.
Kachuri L, Saarela O, Bojesen S, Davey Smith G, Liu G, Landi M . Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers. Int J Epidemiol. 2018; 48(3):751-766. PMC: 6659464. DOI: 10.1093/ije/dyy140. View

2.
Yuan J, Beckman K, Wang R, Bull C, Adams-Haduch J, Huang J . Leukocyte telomere length in relation to risk of lung adenocarcinoma incidence: Findings from the Singapore Chinese Health Study. Int J Cancer. 2018; 142(11):2234-2243. PMC: 5893405. DOI: 10.1002/ijc.31251. View

3.
Haycock P, Burgess S, Nounu A, Zheng J, Okoli G, Bowden J . Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncol. 2017; 3(5):636-651. PMC: 5638008. DOI: 10.1001/jamaoncol.2016.5945. View

4.
Codd V, Wang Q, Allara E, Musicha C, Kaptoge S, Stoma S . Polygenic basis and biomedical consequences of telomere length variation. Nat Genet. 2021; 53(10):1425-1433. PMC: 8492471. DOI: 10.1038/s41588-021-00944-6. View

5.
Seow W, Cawthon R, Purdue M, Hu W, Gao Y, Huang W . Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. Cancer Res. 2014; 74(15):4090-8. PMC: 4119534. DOI: 10.1158/0008-5472.CAN-14-0459. View